Please login to the form below

Not currently logged in
Email:
Password:

AZ

This page shows the latest AZ news and features for those working in and with pharma, biotech and healthcare.

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

Earlier this month, AZ revealed the results of the DAPA-HF trial of its diabetes therapy Farxiga, to an eager crowd at the European Society of Cardiology. ... Farxiga is already growing quickly for AZ, with a possible heart failure claim adding to this

Latest news

More from news
Approximately 72 fully matching, plus 814 partially matching documents found.

Latest Intelligence

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    The firm has just signed a long-term collaboration with AZ for the discovery of new drugs for chronic kidney disease and idiopathic pulmonary fibrosis (IPF). ... The firms will work together to combine. AZ’s genomics, chemistry and clinical data with

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    AZ reported that, between 2012 and 2016, the company improved its success rate considerably in bringing a compound into the clinic through to launch, from 4% to almost 20%. ... While AZ hasn’t ruled it out completely, the potential poses several

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    Galbraith’s unit has not only demonstrated good judgement about picking winning molecules, but has also shown speed: Tagrisso is one of the fastest-ever developed drugs, with AZ taking it

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    Lastly, AZ has also gained three Breakthrough Therapy Designations (including two Orphan Drug Designations) and six additional Priority Review Designations. ... Jane Osbourn, AZ's site lead. The new HQ is specifically designed to foster an open,

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    years for AZ to return to top-line growth after the patent loss of blockbuster brands such as Nexium and Crestor. ... One such project was set up with the Wuxi regional government in 2017, where AZ established a joint venture.

More from intelligence
Approximately 4 fully matching, plus 48 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics